Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.697
-0.018 (-2.56%)
At close: Nov 20, 2024, 4:00 PM
0.717
+0.020 (2.91%)
Pre-market: Nov 21, 2024, 7:22 AM EST
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $157.57 million as of November 21, 2024. Its market cap has increased by 19.85% in one year.
Market Cap
157.57M
Enterprise Value
34.16M
1-Year Change
19.85%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $157.57M, a decrease of -84.17%. That is a compound annual growth rate of -27.29%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MediWound | 168.76M |
| scPharmaceuticals | 167.63M |
| Lineage Cell Therapeutics | 166.18M |
| Fulcrum Therapeutics | 163.43M |
| Tenaya Therapeutics | 163.19M |
| Greenwich LifeSciences | 162.60M |
| Instil Bio | 162.30M |
| The Joint | 161.82M |